Global Skin Transplantation 麻豆原创 Research Report 2024

Publication ID:

PB503245295

Publication Date:

March 15, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Skin grafts are used in a surgical procedure known as skin grafting where the skin is removed form one part of the body and is transplanted to another area where skin is lost due to burns or injuries. The skin graft can be harvested from donor's skin tissue but may lead to a risk of rejection by the recipient's body or infection to the recipient. Various types of equipment used for skin grafting are dermatome, general surgical instruments, and consumables. Skin grafts are performed when the injured skin has lost its capability to heal itself, hence its operational procedure is expensive. In case of severe skin restoration, the physician may need to obtain skin from another donor, which may make the procedure more expensive compared to the cost if the skin would be if the skin is obtained from the same person. Otherwise. The total cost of skin grafting is decided based on factors such as, the hospitalization charges, donor's fees, medications, surgeons鈥� fees, operational charges, post operational charges and consultation fees. The area of wound also determines the cost of the procedure.
The global Skin Transplantation market was valued at US$ 368 million in 2023 and is anticipated to reach US$ 473.4 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
The global skin transplantation market is projected to experience steady growth in the coming years. Skin transplantation, also known as skin grafting, is a surgical procedure that involves the replacement of damaged or diseased skin with healthy skin from another part of the body or from a donor. Several factors are contributing to the growth of the global skin transplantation market. One key factor is the increasing prevalence of skin disorders, burns, chronic wounds, and other conditions that require skin transplantation. Additionally, advancements in medical technology and techniques, such as the development of more effective skin grafting procedures and the use of bioengineered skin substitutes, are expected to drive market growth. Moreover, an aging population, which is more prone to skin-related disorders and injuries, is also anticipated to contribute to market growth. In terms of geographical regions, North America and Europe are expected to dominate the global market due to the presence of advanced healthcare infrastructure and high healthcare expenditure. However, Asia Pacific is projected to witness significant growth, driven by rising awareness, improving healthcare facilities, and the presence of a large population base.
This report aims to provide a comprehensive presentation of the global market for Skin Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Transplantation.
Report Scope
The Skin Transplantation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Transplantation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Smith & Nephew
Mimedex
Zimmer Biomet
Nouvag
De Soutter Medical
Braun Melsungen
Kerecis
Avita Medical
Organogenesis
Tissue Regenix
PolyNovo
Humeca
SYNOVIS Micro Alliance
Regen Medical
Harbor MedTech
Exsurco Medical
Specmed Medical
Swann Morton
Segment by Type
Split-Thickness
Full-Thickness
Composite Graft
Segment by Application
Hospitals
Ambulatory Surgical Centers
Dermatology Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Transplantation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Skin Transplantation 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Split-Thickness
1.2.3 Full-Thickness
1.2.4 Composite Graft
1.3 麻豆原创 by Application
1.3.1 Global Skin Transplantation 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Dermatology Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Transplantation 麻豆原创 Perspective (2019-2030)
2.2 Skin Transplantation Growth Trends by Region
2.2.1 Global Skin Transplantation 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Skin Transplantation Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Skin Transplantation Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Skin Transplantation 麻豆原创 Dynamics
2.3.1 Skin Transplantation Industry Trends
2.3.2 Skin Transplantation 麻豆原创 Drivers
2.3.3 Skin Transplantation 麻豆原创 Challenges
2.3.4 Skin Transplantation 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Transplantation Players by Revenue
3.1.1 Global Top Skin Transplantation Players by Revenue (2019-2024)
3.1.2 Global Skin Transplantation Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Skin Transplantation 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Skin Transplantation Revenue
3.4 Global Skin Transplantation 麻豆原创 Concentration Ratio
3.4.1 Global Skin Transplantation 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Transplantation Revenue in 2023
3.5 Skin Transplantation Key Players Head office and Area Served
3.6 Key Players Skin Transplantation Product Solution and Service
3.7 Date of Enter into Skin Transplantation 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Transplantation Breakdown Data by Type
4.1 Global Skin Transplantation Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Skin Transplantation Forecasted 麻豆原创 Size by Type (2025-2030)
5 Skin Transplantation Breakdown Data by Application
5.1 Global Skin Transplantation Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Skin Transplantation Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Skin Transplantation 麻豆原创 Size (2019-2030)
6.2 North America Skin Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Skin Transplantation 麻豆原创 Size by Country (2019-2024)
6.4 North America Skin Transplantation 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Transplantation 麻豆原创 Size (2019-2030)
7.2 Europe Skin Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Skin Transplantation 麻豆原创 Size by Country (2019-2024)
7.4 Europe Skin Transplantation 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Skin Transplantation 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Skin Transplantation 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Skin Transplantation 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Skin Transplantation 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Skin Transplantation 麻豆原创 Size (2019-2030)
9.2 Latin America Skin Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Skin Transplantation 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Skin Transplantation 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Transplantation 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Skin Transplantation 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Skin Transplantation 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Skin Transplantation 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Smith & Nephew
11.1.1 Smith & Nephew Company Detail
11.1.2 Smith & Nephew Business Overview
11.1.3 Smith & Nephew Skin Transplantation Introduction
11.1.4 Smith & Nephew Revenue in Skin Transplantation Business (2019-2024)
11.1.5 Smith & Nephew Recent Development
11.2 Mimedex
11.2.1 Mimedex Company Detail
11.2.2 Mimedex Business Overview
11.2.3 Mimedex Skin Transplantation Introduction
11.2.4 Mimedex Revenue in Skin Transplantation Business (2019-2024)
11.2.5 Mimedex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Detail
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Skin Transplantation Introduction
11.3.4 Zimmer Biomet Revenue in Skin Transplantation Business (2019-2024)
11.3.5 Zimmer Biomet Recent Development
11.4 Nouvag
11.4.1 Nouvag Company Detail
11.4.2 Nouvag Business Overview
11.4.3 Nouvag Skin Transplantation Introduction
11.4.4 Nouvag Revenue in Skin Transplantation Business (2019-2024)
11.4.5 Nouvag Recent Development
11.5 De Soutter Medical
11.5.1 De Soutter Medical Company Detail
11.5.2 De Soutter Medical Business Overview
11.5.3 De Soutter Medical Skin Transplantation Introduction
11.5.4 De Soutter Medical Revenue in Skin Transplantation Business (2019-2024)
11.5.5 De Soutter Medical Recent Development
11.6 Braun Melsungen
11.6.1 Braun Melsungen Company Detail
11.6.2 Braun Melsungen Business Overview
11.6.3 Braun Melsungen Skin Transplantation Introduction
11.6.4 Braun Melsungen Revenue in Skin Transplantation Business (2019-2024)
11.6.5 Braun Melsungen Recent Development
11.7 Kerecis
11.7.1 Kerecis Company Detail
11.7.2 Kerecis Business Overview
11.7.3 Kerecis Skin Transplantation Introduction
11.7.4 Kerecis Revenue in Skin Transplantation Business (2019-2024)
11.7.5 Kerecis Recent Development
11.8 Avita Medical
11.8.1 Avita Medical Company Detail
11.8.2 Avita Medical Business Overview
11.8.3 Avita Medical Skin Transplantation Introduction
11.8.4 Avita Medical Revenue in Skin Transplantation Business (2019-2024)
11.8.5 Avita Medical Recent Development
11.9 Organogenesis
11.9.1 Organogenesis Company Detail
11.9.2 Organogenesis Business Overview
11.9.3 Organogenesis Skin Transplantation Introduction
11.9.4 Organogenesis Revenue in Skin Transplantation Business (2019-2024)
11.9.5 Organogenesis Recent Development
11.10 Tissue Regenix
11.10.1 Tissue Regenix Company Detail
11.10.2 Tissue Regenix Business Overview
11.10.3 Tissue Regenix Skin Transplantation Introduction
11.10.4 Tissue Regenix Revenue in Skin Transplantation Business (2019-2024)
11.10.5 Tissue Regenix Recent Development
11.11 PolyNovo
11.11.1 PolyNovo Company Detail
11.11.2 PolyNovo Business Overview
11.11.3 PolyNovo Skin Transplantation Introduction
11.11.4 PolyNovo Revenue in Skin Transplantation Business (2019-2024)
11.11.5 PolyNovo Recent Development
11.12 Humeca
11.12.1 Humeca Company Detail
11.12.2 Humeca Business Overview
11.12.3 Humeca Skin Transplantation Introduction
11.12.4 Humeca Revenue in Skin Transplantation Business (2019-2024)
11.12.5 Humeca Recent Development
11.13 SYNOVIS Micro Alliance
11.13.1 SYNOVIS Micro Alliance Company Detail
11.13.2 SYNOVIS Micro Alliance Business Overview
11.13.3 SYNOVIS Micro Alliance Skin Transplantation Introduction
11.13.4 SYNOVIS Micro Alliance Revenue in Skin Transplantation Business (2019-2024)
11.13.5 SYNOVIS Micro Alliance Recent Development
11.14 Regen Medical
11.14.1 Regen Medical Company Detail
11.14.2 Regen Medical Business Overview
11.14.3 Regen Medical Skin Transplantation Introduction
11.14.4 Regen Medical Revenue in Skin Transplantation Business (2019-2024)
11.14.5 Regen Medical Recent Development
11.15 Harbor MedTech
11.15.1 Harbor MedTech Company Detail
11.15.2 Harbor MedTech Business Overview
11.15.3 Harbor MedTech Skin Transplantation Introduction
11.15.4 Harbor MedTech Revenue in Skin Transplantation Business (2019-2024)
11.15.5 Harbor MedTech Recent Development
11.16 Exsurco Medical
11.16.1 Exsurco Medical Company Detail
11.16.2 Exsurco Medical Business Overview
11.16.3 Exsurco Medical Skin Transplantation Introduction
11.16.4 Exsurco Medical Revenue in Skin Transplantation Business (2019-2024)
11.16.5 Exsurco Medical Recent Development
11.17 Specmed Medical
11.17.1 Specmed Medical Company Detail
11.17.2 Specmed Medical Business Overview
11.17.3 Specmed Medical Skin Transplantation Introduction
11.17.4 Specmed Medical Revenue in Skin Transplantation Business (2019-2024)
11.17.5 Specmed Medical Recent Development
11.18 Swann Morton
11.18.1 Swann Morton Company Detail
11.18.2 Swann Morton Business Overview
11.18.3 Swann Morton Skin Transplantation Introduction
11.18.4 Swann Morton Revenue in Skin Transplantation Business (2019-2024)
11.18.5 Swann Morton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Smith & Nephew
Mimedex
Zimmer Biomet
Nouvag
De Soutter Medical
Braun Melsungen
Kerecis
Avita Medical
Organogenesis
Tissue Regenix
PolyNovo
Humeca
SYNOVIS Micro Alliance
Regen Medical
Harbor MedTech
Exsurco Medical
Specmed Medical
Swann Morton

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.